Search research articles
Contact Us
Filters
Showing results (11-20 of 109) with videos related to
Page
of 11
Sort By:
Drugs & Aging
|
September 3, 2010
Metronomic chemotherapy for metastatic prostate cancer: a 'young' concept for old patients?
Andrea Fontana, Alfredo Falcone, Lisa Derosa, et al.
Annual Review of Pharmacology and Toxicology
|
September 11, 2024
Gut Microbiota-Related Biomarkers in Immuno-Oncology
Carolina Alves Costa Silva, Marine Fidelle, Andrew A Almonte, et al.
Cell Research
|
January 14, 2026
Gut dysbiosis in oncology: a risk factor for immunoresistance
Andrew Allan Almonte, Simon Thomas, Valerio Iebba, et al.
Nature Cancer
|
February 5, 2022
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Franck Griscelli, et al.
Clinical Genitourinary Cancer
|
September 11, 2017
Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy
Annalisa Guida, Laurence Albiges, Lisa Derosa, et al.
Comptes Rendus Biologies
|
April 11, 2018
The impact of the intestinal microbiota in therapeutic responses against cancer
Anne-Gaëlle Goubet, Romain Daillère, Bertrand Routy, et al.
Cancer Discovery
|
August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Tumori
|
July 31, 2014
Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report
Elisa Biasco, Andrea Antonuzzo, Claudia Cianci, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 22, 2025
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
Arielle Elkrief, Bertrand Routy, Lisa Derosa, et al.
Oncoimmunology
|
October 9, 2024
Benzodiazepines compromise the outcome of cancer immunotherapy
Léa Montégut, Lisa Derosa, Meriem Messaoudene, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 109) with videos related to
Sort By:
Page
of 11
Drugs & Aging
|
September 3, 2010
Metronomic chemotherapy for metastatic prostate cancer: a 'young' concept for old patients?
Andrea Fontana, Alfredo Falcone, Lisa Derosa, et al.
Annual Review of Pharmacology and Toxicology
|
September 11, 2024
Gut Microbiota-Related Biomarkers in Immuno-Oncology
Carolina Alves Costa Silva, Marine Fidelle, Andrew A Almonte, et al.
Cell Research
|
January 14, 2026
Gut dysbiosis in oncology: a risk factor for immunoresistance
Andrew Allan Almonte, Simon Thomas, Valerio Iebba, et al.
Nature Cancer
|
February 5, 2022
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Franck Griscelli, et al.
Clinical Genitourinary Cancer
|
September 11, 2017
Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy
Annalisa Guida, Laurence Albiges, Lisa Derosa, et al.
Comptes Rendus Biologies
|
April 11, 2018
The impact of the intestinal microbiota in therapeutic responses against cancer
Anne-Gaëlle Goubet, Romain Daillère, Bertrand Routy, et al.
Cancer Discovery
|
August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Tumori
|
July 31, 2014
Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case report
Elisa Biasco, Andrea Antonuzzo, Claudia Cianci, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
April 22, 2025
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
Arielle Elkrief, Bertrand Routy, Lisa Derosa, et al.
Oncoimmunology
|
October 9, 2024
Benzodiazepines compromise the outcome of cancer immunotherapy
Léa Montégut, Lisa Derosa, Meriem Messaoudene, et al.
Page
of 11